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Abstract 
Purpose: To investigate the phytochemical constituents, acute toxicity and biological activities of 
Lobelia herb (dried leaf of Lobelia flaccida; family: Campanulaceae), a popular medicinal agent used to 
manage pain and epilepsy among other indications in Eastern Cape Region of South Africa.  
Methods: Essential oil (EO) obtained from the dried leaf was analysed with gas chromatography-mas 
spectroscopy GC/MS while an infusion extract of the herb was obtained by soaking in hot boiled water 
(100 oC) for 24 h, filtered and the filtrate dried in vacuo. Phytochemical screening of the infusion extract 
was performed to detect the presence of secondary plant metabolites and relative abundance of some 
of the metabolites. The aqueous  extract was evaluated for oral (p.o.) acute toxicity (LD50) using the 
Lorke’s method [30];, thereafter the extract was tested for anti-inflammatory activity on carrageenan-
induced rat paw oedema at 250 and 500 mg/kg, p.o., normal saline and aspirin (100 mg/kg, p.o.) used 
as negative and positive controls respectively. Finally, the extract at 500 and 1000 mg/kg, p.o. was 
tested for anticonvulsant activity on pentylene tetrazol (85 mg/kg, intraperitoneally)-induced convulsion 
model in mice, normal saline and diazepam (1 mg/kg, i.p.) served as negative and positive control 
groups respectively.  
Results: EO yield was 0.022 % w/w and the two major compounds identified were acetophenone 
(26.37 %) and caryophyllene (17.35 %). Phytochemical screening showed high concentration of 
alkaloids, saponins and flavonoids among other constituents. LD50 of the aqueous extract was ≥ 5000 
mg/kg per oral while the aqueous extract exhibited significant (p < 0.01) anti-inflammatory activity on 
carrageenan-induced rat paw oedema comparable to aspirin but insignificant anticonvulsant activity on 
pentylene tetrazol-induced convulsion when compared with diazepam.    
Conclusion: Lobelia herb is non-toxic, and possesses significant anti-inflammatory and mild 
anticonvulsant activities.  It is suggested that the essential oil of this herb should be screened for 
pharmacological activities. 
 
Keywords: Lobelia flaccida, Essential oil, Gas chromatography/mass spectroscopy analysis , Infusion 
extract, Acute toxicity, Anti-inflammatory, Anti-convulsant 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 
(DOAJ), African Journal Online, Bioline International, Open-J-Gate and Pharmacy Abstracts 
 
Stolom et al 




The contribution of natural products particularly 
medicinal plants to discovery of novel drugs have 
been well highlighted [1] and Newman et al [2] 
reported that research on natural products 
accounted for about 48 % of all natural product-
derived compounds between 1981 and 2002. 
Furthermore, Jones et al [3] revealed that 
majority of plant-related drugs on the pharmacy 
shelf as at 1993 actually emanated from 
ethnomedicinal application of most species that 
were indicated for the same therapeutic uses. 
Crude herbs which have long been used as the 
basis for traditional medicines worldwide are still 
invaluable now [4]. The role of traditional 
medicine in mitigating disease burden and 
poverty in the African continent has been 
emphasized and extended to include increasing 
the economic well-being and healthcare 
accessibility of communities. 
 
Lobelia commonly known as Indian tobacco is a 
genus of flowering plants comprising about 415 
species (family: Campanulaceae) with subtle 
distribution in tropical-warm temperate regions of 
the world [5]. L. inflata is regarded as the most 
important variety in this family consisting of 
several species including L. cardinalis, L. erinus, 
L. spitaca, L. siphilitica, L. puberula and L. 
appendiculata [6]. Sixty-nine species occur in 
South Africa, found throughout the country 
growing in a variety of habitats [7,8]. One of the 
commonest species found in the Eastern Cape of 
South Africa is L. flaccida (C. Presl) A.DC, family: 
Campanulaceae known as itshilizi in Ixhosa 
language [8,9] and is the specie investigated in 
this study. Traditionally, different Lobelia species 
has been used for bronchitis and asthma, 
topically for myositis and rheumatic nodules, as a 
diuretic, antidote and as carcinostatic agents for 
stomach cancer in Chinese folk medicine [10,11]. 
Lobelia siphilitica and L. cardinalis were 
historically used in the treatment of syphilis in 
North America [12]. Although several studies 
have been undertaken to evaluate lobeline (an 
alkaloid from Lobelia) as anti-smoking drug, the 
results obtained showed that it was ineffective in 
helping people quit smoking with conflicting 
results [13]. 
 
Reports on the chemical constituents of Lobelia 
species confirmed alkaloids such as lobeline, 
norlobelanine; flavonoid compounds (apigenin, 
luteolin, quercetin), and coumarins; and essential 
oil [14]. Biological studies on Lobelia species 
showed several activities including antimicrobial 
[15], antidepressant [16] anticancer [11] and 
antiepileptic [17] and analgesic and antivenom 
potentials [18].  
The people of the Eastern Cape of South Africa 
depend largely on the use of medicinal plants 
born out of strong belief that they are effective to 
treat many diseases [19]. The Department of 
Science and Technology, South Africa, initiated 
the Indigenous Knowledge System (IKS) Project 
in 2002 in its bid to bridge the gap between the 
herbal practitioners and the academia, improve 
the health care system in the rural areas and 
advance herbal practices in the community.  
 
This is the first study reporting chemical 
composition and biological activities of this 
particular species from the Eastern Cape and the 
aim was to investigate the chemical composition 
of the essential oil; screen the infusion extract for 
secondary metabolites; and then determine the 
acute toxicity profile, anti-inflammatory and 
anticonvulsant [8,11] activities of the crude 
infusion extract of Lobelia flaccida. Thus, this 
study is expected to generate new information 
and to validate the use of this plant in South 




Plant collection, and extraction of essential 
oil and infusion extract  
 
Dried leaves of Lobelia were collected from the 
Herbal Practitioner on 3rd July 2014 at Ginsberg, 
King Williams Town, Eastern Cape, South Africa. 
The leaves were used for the extraction of the 
essential oil and infusion extract. The dried 
leaves of Lobelia were identified by Dr. K 
Immelman, Herbarium Unit, Department of 
Botany, Walter Sisulu University (WSU), 
Mthatha. Essential oil of Lobelia flaccida dried 
leaf was obtained by hydrodistillation using a 
cleavenger-like apparatus and stored in a vial, 
protected from light until sent for analysis. 
Infusion extract of the leaves was obtained 
according to herbal practitioner’s directive. 
Briefly, 100 g of the dried plant material was 
grounded into coarse powders and soaked in 
boiling water with continuous stirring and allowed 
to infuse for 24 h. Thereafter, it was filtered using 
Whatman filter paper; a portion was kept for the 
phytochemical screening, while the remaining 




For qualitative screening, aqueous extract of 
Lobelia flaccida leaf was used while the 
powdered leaf was used for quantitative 
screening according to the method described by 
Mir et al [20]. 
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The infusion filtrate was used for the qualitative 
analysis to detect the presence of secondary 
metabolites including tannins, saponins, 
flavonoids, terpenoids, alkaloids, phenols, 
phytosterols, glycosises, anthraquinones, 
phlobatanninsand proteins/amino acids in the 
aqueous leaf extract of Lobelia flaccida [20]. 
 
Analysis of essential oil of Lobelia leaf 
 
Gas chromatography- flame ionization 
detector (GC-FID) analysis 
 
GC analysis was carried out on a Perkin-Elmer 
8500 gas chromatograph with a FID detector with 
a SGE BP X5 column that is 30 m in length with 
a film thickness of 0.25 µm and diameter 0.25 
mm ID. The operating conditions were as follows: 
carrier gas, nitrogen with a flow rate of 3.0  
ml/min; column temperature, 60 - 275 oC at 4 
oC/min; injector and detector temperature, 280 oC 





GC/MS analysis of the oil was performed on a 
GCMS-QP2010 Gas Chromatography- mass 
spectrometer system operating in EI mode at 70 
eV, equipped with a HP-5 MS fused silica 
capillary system with a 5 % phenylmethylsiloxane 
stationary phase. Capillary column parameter 
was 30 m by 0.25 mm, film thickness 0.25 µm. 
The initial temperature of the column was 70 oC 
and was heated to 250 oC at a rate of 5 oC/min. 
The final temperature was kept at 450 oC and run 
time of 68 min.  Helium was used as the carrier 
gas at a flow rate of 1 ml/min. The split ratio was 
100:1. Scan time was 68 min with a scanning 
range of 35 to 450 amu. One microliter (1 µl) of 
the diluted oil (in hexane) was injected for 
analysis. N-alkane of C8 to C30 was run under 





Mice and rats were obtained from the South 
African Vaccine Initiative, Johannesburg and 
kept at the Animal Holding Facility, Zoology 
Department, Walter Sisulu University WSU. Male 
and female Wistar rats (200-300 g) were 
randomly selected (n=6) for the anti-inflammatory 
test. Swiss mice of both sexes (25-35 g; n=6) 
were also selected for the acute toxicity and the 
anticonvulsant tests. They were kept under 
standard laboratory conditions and had free 
access to rat chow and water. Food was 
however withheld overnight prior to experiments 
while water was provided ad libitum. This study 
was approved by the Department of Higher 
Education, WSU (Ref: DVC (AA&R) DRD/SREC) 
The study was carried out in accordance with the 
"Principles of Laboratory Animal Care", NIH 
publication no. 85-23, revised 1985. 
 
Acute toxicity  
 
Acute toxicity effect of the infusion extract of the 
leaves of Lobelia flaccida was assessed in mice 
using the oral route (p.o.) according to Lorke’s 
method [21]. The method involved using only 
thirteen (13) animals and was divided into 2 
phases. The first phase consists of three (3) sub-
groups (n=3) at dose levels of 10, 100 and 1000 
mg/kg. The second phase involved four (n=1) 
dose levels of 1000, 1600, 2900 and 5000 mg/kg 
respectively. Immediately after treatment, each 
mouse was placed inside the Plexiglas cage and 
observed for immediate effects up to 30 min and 
thereafter for 24 h for lethal effects culminating 
into death. The LD50 of the extract was estimated 
as the geometric mean of the lowest dose 
causing death and the highest dose causing no 
death according to Eq 1. 
 
LD50 = √(AB) . …………………………. (1) 
 
where A is the maximum dose producing 0 % 
death and B is the lowest dose that produced 
100 % death.  
 
Anti-inflammatory activity studies 
 
The anti-inflammatory activity was evaluated by 
the carrageenan-induced paw oedema test in 
rats 22]. The left hind paw was injected with 0.2 
ml of normal saline and used the control. Normal 
saline (10 ml/kg), the extract of Lobelia (250 and 
500 mg/kg) and aspirin (100 mg/kg) were orally 
administered 1 h prior to carrageenan injection 
(0.1 ml 2 % w/v carrageenan in normal saline) to 
4 different groups of rats (n=6). The paw oedema 
sizes were recorded for each rat before 
carrageenan injection and at 1, 2, 3 and 4 h post 
carrageenan injection using Vernier Callipers. 
 
Anticonvulsant activity studies 
 
The anticonvulsant effect was evaluated using 
the pentylenetetrazole (PTZ)-induced convulsion 
model. Pentylenetetrazole (85 mg/kg) was used 
to induce tonic-clonic convulsions [23]. Five 
different groups (n=5) of mice were randomly 
selected and orally pre-treated for 1 h as follows: 
group I received normal saline (10 ml/k), groups 
II-III received extract (500 and 1000 mg/kg) 
respectively and group IV diazepam (1 mg/kg). 
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Thereafter, anticonvulsant assessment was 
carried out with pentylenetetrazole (85 mg/kg, 
i.p.). The animals were observed for the onset of 
convulsion, time of death and mortality. Animals 
that survived beyond 30 min post-





The results are expressed as mean ± standard 
error of mean (SEM) and analysed using one-
way analysis of variance (ANOVA) followed by 
post hoc test using Dunnett’s test for comparison 
between the treated groups and control at p < 
0.05; while the ratio of mortality or protection for 
each group was expressed in percentage. The 
software used are GraphPad Instant R version 
3.0.10.0 (UK) and GraphPad Prism Version 5 




Yield of the essential oil and infusion extract 
 
The yield of the essential oil was 0.22 % w/w, 
which was light yellowish in colour with 
characteristic aromatic odour. The infusion 
extract obtained from the dried leaf of Lobelia 
weighed 25.54 g (25.50 % w/w). 25.54 g (25.5 % 
w/w).  
 
Phytochemical profile of the infusion extract 
of Lobelia flaccida leaf 
 
The results obtained from the qualitative 
screening of Lobelia leaf indicated the presence 
of alkaloids, flavonoids, phenols, phytosterols, 
proteins, saponins and tannins; while 
carbohydrates, glycosides, phlobatannins and 
steroids were not detected. The quantitative 
analysis of Lobelia leaf infusion extract showed 
that the percentage of alkaloid, saponins and 
flavonoids constituents were 2.40, 0.14 and 0.40 
% w/w respectively while its tannin constituent 
was not recoverable. 
 
Composition of Lobelia essential oil 
 
GC/MS analysis of Lobelia essential oil indicated 
the presence of 25 compounds out of which 23 
were fully identified constituting about 98 % of all 
the constituents (Table 1). The major compounds 
identified include acetophenone (26.37 %), 
caryophyllene (8.11 %), borneol (7.46 %) and 
anethole (6.81 %). 
 
Table 1: Chemical composition of the essential oil of L. flaccida 
 
Peak                      
no                                                                                                   
Compounda,b                          Eluting time 
(sec)           
KI Relative % 
composition 
1 α-Pinene 5.205 937 1.40 
2 Benzaldehyde 5.710 957 5.36 
3 2-Pentylfuran 6.210 989 1.15 
4 1,8-cienole 7.225 1030 3.13 
5 Acetophenone 8.010 1065 26.37 
6 Linalool 8.760 1101 3.92 
7 2(10)-Pinen-3-ol, (1S, 3R, 5S) 9.960 1138 0.47 
8 Camphor 10.135 1145 6.56 
9 D-isomenthone 10.310 1162 0.62 
10 Borneol 10.770 1169 7.46 
11 α-Terpineol 11.340 1195 2.35 
12 (-)-Carvone 12.650 1242 2.60 
13 Anethole 13.775 1142 6.81 
14 Phenol,2-methyl-5-(1-methylethyl) 14.050 1152 3.67 
15 α-Terpineol acetate 15.355 1347 1.31 
16 Unidentified 16.720  0.55 
17 Caryophyllene 17.345 1436 8.11 
18 Geranyl acetone 17.865 1438 1.41 
19 β-Humulene 18.240 1483 1.87 
20 (E)- α-Ionone 18.750 1492 2.43 
21 Cadina-1(10),4-diene 19.740 1533 1.80 
22 Caryophyllene oxide 21.330 1588 3.43 
23 Guaiol 21.600 1601 3.13 
24 Unidentified 22.980  0.62 
25 2-Pentadecanone,6,10,14-trimethyl 26.845 1697 3.46 
a[24];  b[25]  
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The classes of compound identified in the oil 
were sesquiterpenes (8.11%), phenyl alkenes 
(6.81 %), monoterpenes (7.46 %) and a simple 
ketone (26.37 %). The major compounds 
obtained were from different classes and they 
play different roles in the Lobelia but the major 
compound is an aromatic ketone acetophenone 
(26.37 %). 
 
Acute toxicity effect of the infusion extract of 
Lobelia dried leaf 
 
There was no mortality at all the doses of the 
infusion extract up to 5000 mg/kg, p.o. The LD50 
was therefore estimated to be ≥ 5000 mg/kg 
through the oral route in mice. 
 
Effect of infusion extract of Lobelia leaf on 
carrageenan-induced rat paw oedema 
 
Rats pre-treated with normal saline had 
increased paw sizes throughout the 4-hour 
period of observation. Infusion extract of Lobelia, 
250-500 mg/kg caused significant (p < 0.01) 
reduction in paw oedema sizes at 1, 2, 3  and 4 h 
post-carrageenan injection compared to control 
group. Also, aspirin (100 mg/kg) similarly caused 
significant (p < 0.01) reduction in the rats’ paw 
oedema (Figure 1). 
 
Effect of the infusion extract of Lobelia leaf 
against PTZ-induced convulsion 
 
All the mice in the control group convulsed and 
died within 30 min post-PTZ (85 mg/kg, i.p.). The 
extract delayed the onset of convulsion and time 
of death after convulsion compared to vehicle 
although not statistically significant. Diazepam, (a 
standard anticonvulsant drug used) caused 
significant (p < 0.01) delay in onset of convulsion 
and protected the mice against PTZ-induced 
death. However, Lobelia at 500 and 1000 mg/kg 
offered 40 and 20 % protections against the PTZ-
induced mortality respectively compared to the 
group’s 0 % and diazepam’s 100 % protection at 




Phytochemical screening of Lobelia leaf 
confirmed the presence of several metabolites 
including alkaloids, saponins, flavonoids, 
phenols, phytosterols, proteins and tannins. 






































Figure 1: Effect of Lobelia leaf infusion on carrageenan induced rat paw oedema. Key: LOB 250: Lobelia 
infusion extract 250 mg/kg, LOB 500: Lobelia infusion extract 500 mg/kg, ASA:  aspirin 100 mg/kg and VEH: 
normal saline; **p <0.01; at 1 h, F(3, 20) = 20; at 2 h, F(3, 20) = 14.7; at 3 h, F(3, 20) = 16.0;  at 4 h, F(3, 20) = 22.9 
Table 2: Effect of the infusion extract of L. flaccida on PTZ-induced convulsion in mice 
 
Treatment                                Convulsion latency(s)  Time of death (s)                    % Protection       %  Mortality     
                                                    Mean±SEM                     Mean±SEM  
Normal saline 5.20 ± 3.69 349.4 ± 94.4  0 100 
Lobelia 500 mg/kg 161.4 ± 92.30 1038.0 ± 354.6 40 60 
Lobelia 1000mg/kg 91.0 ± 23.47 919.8 ± 260.3  20 80 
Diazepam 1 mg/kg 1505 ± 295.0** 1800 ± 0.0** 100 0 
**P < 0.01, F(3,16) = 21; statistically different from other groups; ANOVA, Dunnett’s 
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These phyto-constituents have variously been 
shown to be responsible for many bioactivities 
displayed by plants and new compounds can be 
discovered by probing them further. It must be 
noted however, that plant extract contains low 
concentrations of active compounds and a large 
number of promising compounds especially 
Lobelia species [17,18]. The essential oil 
analysis revealed the major compounds present 
in the Lobelia flaccida dried leaf to be 
acetophenone (26.37 %) caryophyllene (8.11 %), 
borneol (7.46 %) and anethole (6.81 %). There 
was scanty information in literature on the 
chemical composition of essential oil of this 
Lobelia specie. However, Joshi et al [15] 
reported that perilla ketone (25.61 %), 
camphorquinone (12.16 %), dibutyl phthalate 
(10.66 %) and allylnonanoate (8.47 %) were the 
main constituents of essential oil of Lobelia 
pyramidalis (Wall) from India. The oil composition 
in the present study is different in the class of 
compounds constituting it. Our report showed 
that there were more monoterpenes and 
sesquiterpenoids present as compared to that of 
Joshi et al [15]. 
 
Acute toxicity profile of the Lobelia flaccida dried 
leaf aqueous extract indicated an LD50 of ≥5000 
mg/kg, p.o., indicating that it is non-toxic [21]. 
This toxicity test result can be used to explain 
why the plant is a popular medicinal agent that 
has been used extensively over the years without 
report of serious adverse effects. 
 
Carrageenan-induced paw oedema continues to 
be a valuable experimental animal model for 
acute inflammation which is strongly speculated 
to be biphasic viz. early phase (1-2 h) mediated 
by histamine and serotonin, and late phase (>2 
h) mediated by bradykinin, leukotrienes and 
prostaglandins [26]. In this study, Lobelia extract 
significantly inhibited paw oedema induced by 
carrageenan in both phases, suggesting possible 
inhibition of release of inflammatory mediators 
and cyclooxygenase synthesis similarly to 
nonsteroidal antiinflammatory drugs such as 
aspirin, whose mechanism of action is inhibition 
of the cyclooxygenase pathway. The results 
obtained here support the ethno-medicinal claims 
ascribed to this particular plant species found in 
South Africa by the herbal practitioner. The 
screening of this plant extract showed high 
flavonoid content (4 % w/w) which has been 
previously linked to the antiinflammatory activity 
of L. chinensis [10], it can therefore be postulated 
here that the antiinflammatory activity of this 
Lobelia extract could be associated with the high 
flavonoids and or saponins present in it [27,28]. 
 
The anticonvulsant test indicated that Lobelia 
infusion extract did not significantly alter the 
onset of convulsion or time of death compared to 
the vehicle, but it did prolong insignificantly the 
latency and time of death caused by the PTZ 
compared to the vehicle. Previous studies have 
indicated that the extract of this plant showed 
anticonvulsant potentials in many models of 
convulsion and lobeline isolated from the leaf of 
L. nicotianaefolia demonstrated significant 
anticonvulsant activity [29]. Considering the fact 
that it was just the infusion extract that was used 
in this study, extraction with other solvents such 
as ethanol would probably have demonstrated 
greater anticonvulsant activity because more 
bioactive substances would be extracted. Also, 
the essential oil component which was not tested 
against convulsion due to low quantity obtained 
in this study may exhibit greater activity since 
essential oils of many plants demonstrate 




The major component found in the essential oil of 
this L. flaccida species is caryophyllene. The 
infusion extract is non-toxic, possesses strong 
anti-inflammatory activity but mild anticonvulsant 
activity. Thus justifies the plant’s use in traditional 






This study was funded by NRF research grant 
no. 82640 (IKS 2012.01.19_10163). We also K 
Immelman (KEI herbarium) for her assistance in 
identifying the medicinal plant material. 
 
Conflict of Interest 
 
No conflict of interest associated with this work. 
 
Contribution of Authors 
 
The authors declare that this work was done by 
the authors named in this article and all liabilities 
pertaining to claims relating to the content of this 




1. Lee KH. Current developments in the discovery and 
design of new drug candidates from plant natural 
product lead. J Nat Prod 2004; 67: 273–283. 
Stolom et al 
Trop J Pharm Res, August 2016; 15(8): 1721  
 
2. Newman DJ, Cragg GM, Snader KM. Natural products as 
sources of new drugs over the period 1981–2002. 
Journal of Natural Products 2003; 66(7): 1022–1037. 
3. Jones WP, Chin Y-W, Kinghorn AD. The role of 
pharmacognosy in modern medicine and pharmacy. 
Current Drug Targets 2006; 7: 247-264. 
4. Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical 
constituents of some Nigerian medicinal plants. African 
Journal of Biotechnology 2005; 4: 685-688. 
5. Felpin FX, Lebreton J.  History, chemistry and biology of 
alkaloids from Lobelia inflate. Tetrahedron 2004; 60: 
10127–10153.  
6. Leistner OA. Seed plants of Southern Africa: families and 
genera. Pretoria; Strelitzia10; National Botanical 
Institute; 2000. 
7. Cupido CN, Conrad F. Lobelias in South Africa. Veld & 
Flora 2001; 83: 118-119.  
8. Germishuizen G, Meyer NL. Plants of Southern Africa: an 
annotated checklist. Pretoria; National Botanical Institute 
2003; 14: 941. 
9. Dold AP, Cocks ML. Preliminary list of Xhosa plant 
names from the Eastern Cape, South Africa. Bothalia 
1999; 29(2): 267-292. 
10. Yang S,  Shen T,  Zhao L, , Li C, Zhang Y, Lou H, Ren D. 
Chemical constituents of Lobelia chinensis. Fitoterapia 
2014; 93: 168–174. 
11. Chen M, Chen W, Zhang J, Long X, Wang Y. Lobelia 
chinensis: Chemical constituents and anticancer activity 
perspective. Chin J Nat Med 2014; 12(2): 103-107. 
12. Vigneshwaran V, Somegowda M. Pramod SN. 
Pharmacological Evaluation of Guédon, MF. Sacred 
Smudging in North America; Walkabout Press. (2000). 
13. Glover ED, Rath JM, Sharma E, Glover PN, Laflin M, 
Tonnesen P,  Repsher L, Quiring J.A multicenter phase 
3 trial of lobeline sulfate for smoking cessation. Am J 
Health Behav2010; 34(1): 101-109. 
14. Han J, Zhang F, Li Z, Du G, Qin H. Chemical constituents 
of Lobelia chinensis [J]. Chin Tradit Herbal Drugs 2009; 
34(17): 2200-2202. 
15. Joshi S, Mishra D, Bisht G, Khetwal KS. Essential oil 
composition and antimicrobial activity of Lobelia 
pyramidalis Wall. EXCLI 2011; 10: 274-279. 
16. Subarnas A, Oshima Y, Sidik, Ohizumi Y. An 
antidepressant principle of Lobelia inflata 
(Campanulaceae). J Pharm Sci 1992); 53(7): 620-621. 
17. Tamboli AM, Rub RA, Ghosh P, Bodhankar S. 
Antiepileptic activity of lobeline isolated from the leaf of 
Lobelia nicotianaefolia and its effect on brain GABA 
level in mice. Asian Pac. J. Trop Biomed 2012; 2(7): 
537-542.  
18. Cocks ML, Moller V. Use of indigenous and indigenised 
medicines to enhance personal well-being: a South 
African case study. SocSci Med 2002; 54: 387-397.  
19. Vigneshwaran V, Somegowda M. Pramod SN. 
Pharmacological Evaluation of Analgesic and Antivenom 
Potential from the Leaves of Folk Medicinal Plant 
Lobelia nicotianaefolia. AJPCT 2014; 2(12): 1404-1415. 
20. Mir AM, Sawhney SS, Jassal MMS. Qualitative and 
quantitative phytochemical screening of Tarraxacum 
officinale. Wudpecker J Pharm Pharmacol 2013; 2(1): 
001-005. 
21. Lorke D. A new approach to practical acute toxicity 
testing. Arc Toxicol 1983; 54: 275-287. 
22. Olajide AO, Awe SO, Makinde JM, Ekhelar AI, Olusola A, 
Morebise O, Okpako DT. Studies on the anti-
inflammatory, antipyretic and analgesic properties of 
Alstonia boonei stern bark. J. Ethnopharmacol 2000; 71: 
179–186.  
23. Swinyard EA, Woodhead JH, White HS, Franklin MR. 
Experimental selection qualification and evaluation of 
anticonvulsants. In: Levy R, Mattaon R, Meldrum BS, 
Penry JK, Dreifuss FE (Eds) Antiepileptic Drugs, 3rded. 
New York: Raven Press; 1989; pp 85-102.  
24. Adams RP. Identification of Essential Oil Components: 
GC/Mass Spectroscopy.  4th Ed. USA; Allured 
Publishing Corporation, 336 Gunderson Drive, Suite A, 
Carol Stream, IL; 2007. 
25. ESO 2000. The Complete Database of Essential Oils. 
The Netherlands; Boelens Aroma Chemical Information 
Service; 1999.  
26. Vane JR, Botting RM. New insights into the mode of 
action of anti- inflammatory drugs. Inflammation 
Research 1999; 44(1): 1–10. 
27. Kuo PC, Hwang TL, Lin YT, Kuo Y-C, Leu Y-L. Chemical 
constituents from Lobelia chinensis and their anti-virus 
and anti-inflammatory bioactivities [J]. Arch Pharm 
Res2011; 34(5): 715-722. 
28. Damas J, Bourdon V, Remacle-Volon G, Lecomte J. Pro-
inflammatory flavonoids which are inhibitors of 
prostaglandin biosynthesis. Prostaglandins Leuko Med 
1985); 19: 11-24. 
29. de Almeida RN, Agra Mde F, Maior FN, de Sousa DP. 
Essential oils and their constituents: anticonvulsant 
activity. Molecules 2011; 16(3): 2726-2742. 
 
